Log in
Enquire now
‌

US Patent 10457717 Engineered polypeptides

Patent 10457717 was granted and assigned to Denali Therapeutics on October, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Denali Therapeutics
Denali Therapeutics
Current Assignee
Denali Therapeutics
Denali Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10457717
Date of Patent
October 29, 2019
Patent Application Number
15934744
Date Filed
March 23, 2018
Patent Citations Received
‌
US Patent 11912778 Methods of engineering transferrin receptor binding polypeptides
0
‌
US Patent 10870837 Fusion proteins comprising enzyme replacement therapy enzymes
‌
US Patent 11866742 Fusion proteins comprising enzyme replacement therapy enzymes
0
Patent Primary Examiner
‌
Karlheinz R. Skowronek
Patent abstract

Provided herein are polypeptides that bind to a blood-brain barrier (BBB) receptor, methods of generating such polypeptides, and methods of using the polypeptides to target a composition to a BBB receptor-expressing cell, e.g., for transport across the BBB. Also provided herein are transferrin receptor (TfR) constructs that comprise a monomeric TfR apical domain or one or more portions of the TfR apical domain which have been circularly permuted relative to the full-length TfR sequence.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10457717 Engineered polypeptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.